DYRK1A and diabetes mellitus: Inhibition of DYRK1A expression reduced the synthesis and release of inflammatory factors in keratinocytes caused by a high-glucose environment, which suggested that DYRK1A may be involved in the hyperglycemia-induced inflammatory response in diabetes.